OpenVSafe by OpenVAERS
Search V-safe

AGD-10666-07240

3 vaccinations 3 coded responses 16 check-ins 3 free-text entries 2 call cases
Sex
Female
Age at first dose
56-60
ZIP prefix
981 / WA
Registered
2021-12-01
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-27
    Dose 1 — Pfizer-BioNTech
  2. 2021-04-17
    Dose 2 — Pfizer-BioNTech
  3. 2021-12-01
    Registered in v-safe
  4. 2021-12-01
    Dose 3 — Pfizer-BioNTech
  5. 2021-12-01
    Health check-in — day 0, dose 3
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  6. 2021-12-02
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain, Redness · Fatigue or tiredness
    Adult check-in
  7. 2021-12-03
    Survey response — days 1–6 daily, dose 3
    MedDRA: Dizziness — Feeling: Good · Site: Pain, Redness · Fatigue or tiredness
    Free text: Some lightheaded mess--don't know if related
    MedDRA releases: 2024-11 · check-in free text available
  8. 2021-12-04
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  9. 2021-12-05
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  10. 2021-12-06
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  11. 2021-12-07
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  12. 2021-12-08
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  13. 2021-12-15
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  14. 2021-12-22
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  15. 2021-12-29
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  16. 2022-01-05
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  17. 2022-01-12
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  18. 2022-03-03
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  19. 2022-06-01
    Survey response — 6 months, dose 3
    MedDRA: Balance disorder, Dizziness, Inflammation, Labyrinthitis, Physiotherapy, Pre-existing disease, Tinnitus, Vertigo, Vestibular migraine — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: Symptoms: Labyrinthitis; potentially Ménière's disease. Chronic auditory nerve inflammation and tinnitus. Balance and dizziness (vertigo) at onset in March have improved but inflammation/tinnitus/vestibular migraines persist. · Healthcare visit (other): Vestibular therapist
    MedDRA releases: 2024-11 · check-in free text available
  20. 2022-06-01
    Report sent to call center — 6 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
  21. 2022-06-02
  22. 2022-06-03
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  23. 2022-12-01
    Survey response — 12 months, dose 3
    MedDRA: Postmenopausal haemorrhage, Vestibular neuronitis — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: Last time reported acute left ear neuritis, continuing since March 2022. In July and October 2022 had post menopausal bleeding (15 years after menopause). Endometrial biopsy negative.
    MedDRA releases: 2024-11 · check-in free text available
  24. 2022-12-01
    Report sent to call center — 12 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
  25. 2022-12-02

Vaccinations

DoseDateManufacturerCo-administered
12021-03-27Pfizer-BioNTech No
22021-04-17Pfizer-BioNTech No
32021-12-01Pfizer-BioNTech No

Call center

2 call center cases

1 successful · 1 unsuccessful

See the call center timeline

Free text

Release 10 — days 1–6 daily, dose 3

2021-12-03

Systemic reaction (other): Some lightheaded mess--don't know if related

Release 11 — 6 months, dose 3

2022-06-01

Symptoms: Labyrinthitis; potentially Ménière's disease. Chronic auditory nerve inflammation and tinnitus. Balance and dizziness (vertigo) at onset in March have improved but inflammation/tinnitus/vestibular migraines persist.
Healthcare visit (other): Vestibular therapist

Release 12 — 12 months, dose 3

2022-12-01

Symptoms: Last time reported acute left ear neuritis, continuing since March 2022. In July and October 2022 had post menopausal bleeding (15 years after menopause). Endometrial biopsy negative.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOPhysiotherapy · · ✓
SDBalance disorder · · ✓
SDDizziness · · ✓
SDInflammation · · ✓
SDLabyrinthitis · · ✓
SDPostmenopausal haemorrhage · · ✓
SDPre-existing disease · · ✓
SDTinnitus · · ✓
SDVertigo · · ✓
SDVestibular migraine · · ✓
SDVestibular neuronitis · · ✓
SRODizziness · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release